Item 2.02 Results of Operations and Financial Condition.

On November 5, 2020, Editas Medicine, Inc. (the "Company") issued a press release announcing financial results for the fiscal quarter ended September 30, 2020 and other business highlights. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "Filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.




Item 9.01       Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.                                        Description
99.1         Press release issued by the Company on November 5, 2020*
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

* This exhibit shall be deemed to be furnished and not filed.

© Edgar Online, source Glimpses